Cara Therapeutics | CARA - Aktuelle Verpflichtungen

Aktienkurs
2.92
Täglich Wechseln
0.02 0.77%
Monatlich
-24.88%
Jährlich
-82.45%
Q2 Prognose
2.82




Aktuelle Verpflichtungen Veränderung Datum
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Alterity Therapeutics Limited AUD 1.73M 2.77M 2025-12
Assertio Holdings USD 166.78M 34.25M 2025-09
Cara Therapeutics USD 11.04M 362K 2025-09
Cassava Sciences USD 43.83M 4.21M 2025-12
Chugai Pharma JPY 411.08B 143.65B 2025-12
Cipla INR 62.97B 8.13B 2025-09
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 22.57M 2.29M 2025-12
CSL USD 4.61B 207M 2025-12
Grifols EUR 2.37B 156.97M 2025-12
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
J&J USD 54.13B 3.26B 2025-12
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Pacira USD 120.59M 13.51M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
RedHill Biopharma USD 22.29M 64K 2025-06
Supernus Pharmaceuticals USD 338.17M 7.54M 2025-12
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12